Dong-A ST

Dong-A ST is a leading pharmaceutical company dedicated to the development, manufacturing, and distribution of innovative healthcare solutions. Dong-A ST focuses on ethical drugs, including domestically developed new drugs like Stillen, Zydena, and Motilitone, as well as medical devices and diagnostics. With a commitment to advancing medical science, Dong-A ST operates with optimized research infrastructures, including a world-class research center completed in 2011.

Located at Primary: 64, Cheonho-daero, Dongdaemun-gu, seoul, KR, Dong-A ST is dedicated to expanding its global presence. The company leverages its advanced research capabilities and experienced researchers to develop global new drugs. Dong-A ST also maintains locations at 21 Geumhwa-ro 105beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, KR; 45 Jisikgiban-ro, Yeonsu-gu, Incheon, KR; and 545 Concord Avenue Suite 210, Cambridge, US.

Dong-A ST is poised for continued growth and success in the pharmaceutical industry. By positively exploring overseas markets and expanding its exports, Dong-A ST aims to solidify its position as a global pharmaceutical leader. We invite the management team at Dong-A ST to create a customized and exclusive company showcase and product listing on our platform to further amplify your market presence.